Milrinone for long-term pharmacologic support of the status 1 heart transplant candidates
- 1 June 2000
- journal article
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 69 (6) , 1823-1826
- https://doi.org/10.1016/s0003-4975(00)01313-8
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Mortality remains high for outpatient transplant candidates with prolonged (>6 months) waiting list timeJournal of the American College of Cardiology, 1999
- Parenteral inotropic support for advancedcongestive heart failureProgress in Cardiovascular Diseases, 1998
- Home Inotropic Therapy in Advanced Heart FailureChest, 1997
- Multivariate analysis of factors affecting waiting time to heart transplantationThe Annals of Thoracic Surgery, 1996
- Comparative efficacy of short‐term intravenous infusions of milrinone and dobutamine in acute congestive heart failure following acute myocardial infarctionClinical Cardiology, 1996
- Effects of intravenous milrinone on left ventricular function in ischemic and idiopathic dilated cardiomyopathyThe American Journal of Cardiology, 1993
- Phosphodiesterase III inhibition or adrenoreceptor stimulation: Milrinone as an alternative to dobutamine in the treatment of severe heart failureAmerican Heart Journal, 1991
- Effect of phosphodiesterase inhibition on myocardial oxygen consumption and coronary blood flowThe American Journal of Cardiology, 1989
- Present Use of Positive Inotropic Drugs in Heart FailureJournal of Cardiovascular Pharmacology, 1989
- Vasodilator and inotropic drugs for the treatment of chronic heart failure: Distinguishing hype from hopeJournal of the American College of Cardiology, 1988